President-elect Donald Trump: Turnaround time

This report provided by PwC’s Health Research Institute (HRI) examines the latest proposed healthcare agenda by the new President of the United States, Donald Trump. HRI provides a summary of the political and economic factors that may impact his proposals and the key business considerations from the health industry, through interviewing industry and association leaders from the provider, insurance and pharmaceutical/life sciences sectors, as well as policy experts. PwC’s URI provides new intelligence, perspectives and analysis on trends affecting global health industry. For further discussion on these topic, please contact Audrey Tseng.

Contact us

Zoe Chou

Zoe Chou

Partner, PwC Taiwan

Tel: +886 2 27296666, x26683

Pei-Chuan Huang

Pei-Chuan Huang

Partner, PwC Taiwan

Tel: +886 2 27296666, x26030

Kuan-Hung Lin

Kuan-Hung Lin

Partner, PwC Taiwan

Tel: +886 2 27296666, x26298

Follow us